VYOME HOLDINGS, INC. Inventory Write-down
VYOME HOLDINGS, INC. (HIND) reported Inventory Write-down of $359.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2025-08-14
- VYOME HOLDINGS, INC. inventory write-down for the quarter ending 2024-12-31 was $219.00K, a 6.41% decline year-over-year.
- VYOME HOLDINGS, INC. inventory write-down for the quarter ending 2024-09-30 was $29.00K, a 14.71% decline year-over-year.
- VYOME HOLDINGS, INC. inventory write-down for the quarter ending 2024-06-30 was $156.00K, a 168.97% increase year-over-year.
- VYOME HOLDINGS, INC. inventory write-down for the quarter ending 2024-03-31 was -$45.00K, a 600.00% decline year-over-year.
- VYOME HOLDINGS, INC. inventory write-down for fiscal 2024 was $359.00K, a 7.16% increase from fiscal 2023.
- VYOME HOLDINGS, INC. inventory write-down for fiscal 2023 was $335.00K, a 42.14% decline from fiscal 2022.
- VYOME HOLDINGS, INC. inventory write-down for fiscal 2022 was $579.00K, a 96.94% increase from fiscal 2021.
- VYOME HOLDINGS, INC. inventory write-down for fiscal 2021 was $294.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $248.00K derived: sum of 2 quarters · filed 2025-04-04 | $404.00K derived: sum of 3 quarters · filed 2025-08-14 | $359.00K 10-K · filed 2025-04-04 | |
| 2024-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $185.00K derived: sum of 2 quarters · filed 2025-08-14 | $140.00K 10-Q · filed 2024-11-14 | $374.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $111.00K 10-Q · filed 2025-08-14 | $345.00K derived: sum of 3 quarters · filed 2025-08-14 | $379.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$45.00K 10-Q · filed 2025-05-20 | $189.00K derived: sum of 2 quarters · filed 2025-05-20 | $223.00K derived: sum of 3 quarters · filed 2025-05-20 | $281.00K derived: sum of 4 quarters · filed 2025-05-20 | |
| 2023-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $268.00K derived: sum of 2 quarters · filed 2025-04-04 | $326.00K derived: sum of 3 quarters · filed 2025-04-04 | $335.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $92.00K derived: sum of 2 quarters · filed 2024-11-14 | $101.00K 10-Q · filed 2024-11-14 | $532.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $67.00K 10-Q · filed 2024-08-14 | $498.00K derived: sum of 3 quarters · filed 2024-08-14 | $517.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $9.00K 10-Q · filed 2024-05-15 | $440.00K derived: sum of 2 quarters · filed 2024-05-15 | $459.00K derived: sum of 3 quarters · filed 2024-05-15 | $510.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $450.00K derived: sum of 2 quarters · filed 2024-04-01 | $501.00K derived: sum of 3 quarters · filed 2024-04-01 | $579.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $70.00K derived: sum of 2 quarters · filed 2023-11-09 | $148.00K 10-Q · filed 2023-11-09 | $280.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $129.00K 10-Q · filed 2023-08-07 | $261.00K derived: sum of 3 quarters · filed 2023-08-07 | $410.00K derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $78.00K 10-Q · filed 2023-05-15 | $210.00K derived: sum of 2 quarters · filed 2023-05-15 | $359.00K derived: sum of 3 quarters · filed 2023-05-15 | $371.00K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $281.00K derived: sum of 2 quarters · filed 2023-04-17 | $293.00K derived: sum of 3 quarters · filed 2023-04-17 | $294.00K 10-K · filed 2023-04-17 | |
| 2021-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $161.00K derived: sum of 2 quarters · filed 2022-11-14 | $162.00K 10-Q · filed 2022-11-14 | $209.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $13.00K 10-Q · filed 2022-08-19 | $60.00K derived: sum of 3 quarters · filed 2022-08-19 | $160.00K derived: sum of 4 quarters · filed 2022-08-19 | |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-23 | $48.00K derived: sum of 2 quarters · filed 2022-05-23 | $148.00K derived: sum of 3 quarters · filed 2022-05-23 | $248.00K derived: sum of 4 quarters · filed 2022-05-23 | |
| 2020-12-31 | $47.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2021-05-12 | $147.00K derived: sum of 2 quarters · filed 2021-05-12 | $247.00K derived: sum of 3 quarters · filed 2021-05-12 | $100.00K 10-Q · filed 2021-05-12 | $53.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-06 | $200.00K derived: sum of 2 quarters · filed 2020-11-06 | $53.00K 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $100.00K 10-Q · filed 2020-07-30 | $53.00K 10-Q · filed 2020-07-30 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 10-K · filed 2021-03-12 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |